The Journal of Nuclear Biology Medicine and Allied Sciences 1992: Vol 36 Index

9 Pages·1992·2.4 MB·English

Quarterly Journal in English,
established in 1957 as Minerva Nucleare, THE JOURNAL OF
the first scientific journal in the world
specifically devoted to Nuclear Medicine NUCLEAR BIOLOGY AND MEDICINE
VOLUME 36 - 1992
Subjects Index - Authors’ Index
Subjects Index
A Biliary tract cancer, serum tumor markers, Captopril scintigraphy, renal artery revascu-
Z2%. larization, 120.
All and neuroendocrine tumors diagnosis, Bis(dithiocarbamate) nitrido technetium(V), Carcinoid, '*I-MIBG therapy, 80.
150. preparation and biodistribution, 124. Cardiac dysfunction, "Tc-MIBI, 207.
ACE-inhibitors, 145. Blood pool, § II-134. — equilibrium gated nuclide angiocardiogra-
—and *™Tc-HMPAO SPECT, 132. Blood pressure control, Captopril renal scin- phy, 207.
Acute myocardial infarction, 169, S II-139, tigraphy, 120. Cardiac function in diabetics, S I-148.
S 11-149. Blood-brain barrier, 46. Cardiac sarcoplasmatic reticulum, § II-146.
— atrial natriuretic peptide, 79. Bone density, dual energy x-ray absorptio- Cardiomyopathy, § II-134.
Acute rejection, 2, S II-52. metry, 71. Cardiovascular adaptation in middle-age, S
Adenosine myocardial scintigraphy, S II-73. — kidney transplantation, 72. II-164.
— *!'T] myocardial scintigraphy, 225. — quantitative computerized tomography, Cardiovascular nuclear medicine, 291.
AIDS dementia and brain SPECT, 125. 71. Carotid scintigraphy, 171.
— lung infections, 202. — single photon absorptiometry, 71. Catamenial epilepsy, brain functional ima-
Algorithm, in sequential radionuclide studies, — Procollagen-l, 72. ging, 90.
119. Bone marrow, scintigraphy, 303. Cathepsin D, breast cancer, 138.
Ambulatory radionuclide monitoring, 168. Bone metastasis, 52. CEA test, colorectal cancer, 84.
— detector in left ventricular function, 117. Bone scintigraphy, 52, 303. Cercaria, 56.
Anatech RB86, production of FDG, 172. Brain SPECT in childhood epilepsy, 130, Cerebral blood flow, carbamazepine thera-
Angina pectoris, S I-42. 319. py, 208.
Angiography data, S II-152. — in post-anoxic coma, 109. — pain, 200.
Anthracyclines cardiotoxicity, S II-160. Brain tumors, with 7°'Tl and SPECT, 101. Cerebral disorders, FDG distribution, 176.
— 'In-antimyosin scintigraphy, 109. Brain, functional imaging, 90. Cerebral gliomas, °"Tc-PAO-biotin, 169.
— echocardiography, 109. Breast cancer, and CA15.3, 115. — anti-Tenascin Moab, 169.
— radionuclide ventriculography, 109. — and CA549, 102. Cerebral perfusion, motor deficit improve-
Anti-DD Dimer MoAb, thrombi immunode- — follow-up, 85. ment, 173.
tection, 207. — isoenzimatic markers, 137. Cerebral SPECT and neuropsychometrical
Anti-hydrazidophosphine, 296. — markers, 138. tests, 147.
Anti-TSH-receptor antibody, thyroidectomy, — staging by lymphoscintigraphy, 96. Cerebrospinal fluid, thymidine kinase, 166.
197.
Breast neoplasms, 7, 52. Child, 319.
Antibodies, anti-tumor monoclonal, 7.
Breast tumors and IUdR injection, 154. Childhood epilepsy, °°"Tc-HMPAO, 130,
Antimyosin scan, S$ II-134, S II-154.
319.
Arterial hypertension, S II-42.
Chronic rejection, S$ II-52.
Arteriopathy, "Tc-MIBI, 118.
Cc Collateral circulation in post-infarction, 141.
Arthroprothesis, three-phase scintigraphy, 170.
Colorectal cancer, CEA test, 84.
Atherosclerosis, S I-35.
Ca 15.35, Sz. — diagnosis, 69.
Atrial natriuretic peptide, 79.
— breast cancer, 85, 115, 219. — follow-up, 69.
— kinetic analysis, 143.
CA-549, breast cancer markers, 157. — immunoscintigraphy, 69.
Atrophic chronic gastritis, 114.
— breast cancer, 102. — radioimmunoguided surgery, 205.
— dyspeptic symptoms, 114.
— gastric emptying, 114. CA19-9, mucine-like antigen, 95. Computer resources, procedure, 108.
Autoradiography, 46. CASO, mucine-like antigen, 95. Contractile function, S$ II-82.
CA195, mucine-like antigen, 95. Coronary angiography, S II-167.
Calcitonin, radioimmunoassay kits, 161. — IMA post thrombolytic therapy, 231.
B Calcium ATPase, S II-146. — artery angiography, S 11-68.
Calcium metabolism, kidney transplantation, Coronary artery bypass, S$ II-68, S II-142.
'°B neutron capture therapy, and tumor, 123. ta Coronary artery disease, 26, S II-68, S I-73,
Bi2/Folate, simultaneous radioassay, 196. Cancer risk, 7°'T1 treatment, 122. S II-102, S II-140, S$ II-141, S II-153, S
BC-2 MoAb, Tenascin, 230. Captopril renography, 309. [I-162.
Vol. 36 - 1992 THE JOURNAL OF NUCLEAR BIOLOGY AND MEDICINE
SUBJECTS INDEX
Coronary artery disease, "Tc-MIBI gated Esophagogastroplasty, scintigraphy, 86. Hyperthyroidism, "I treatment, 75.
SPECT, 89. Essential hypertension and intravascular fluid Hypoperfusion, S II-126.
— 7], 117. volume, 134. Hypothyroidism, after "I treatment, 75.
— ambulatory radionuclide detector, 117. Exercise in ventricular function, S II-150. Hypoxia, 56.
— dipyridamole test, 83.
— exercise test, 83.
— myocardial scintigraphic perfusion, 206. F I
— radionuclide ventriculography, 206.
Coronary bypass, S II-146. 18F deoxyglucose (FDG), $ II-62. Ileum, Crohn’s disease, scintigraphy, 119.
Coronary hyperemia, §S II-73. — labeled 2-fluoro 2-deoxyglucose (FDG), IMA post thrombolytic therapy, S II-167.
Coronary microvascular disease, S$ II-42. 267. *I-MIBG, childhood neuroblastoma, 110.
Coronary revascularization, 280. -— FDG PET in multiple systemic atrophy, = phantom studies, S$ II-160.
Crohn’s disease, and 'In-leukocyte scinti- 140. — scintigraphy in thyroid cancer, 77
graphy, 93, 119. — FDG/PET and hybernating myocardium, — IL2, HPLC purification, 212.
146. — insulin kinetics, 213.
— FDG, automated production, 172. — MIBG, chemodectoma, SPECT imaging,
D — SPECT, glucose metabolism, 176. 251.
Fluoxetine, serotonin reuptake inhibition, — IBZM, dopaminergic receptor tracer, 107.
Detection of residual ischemia, S II-165. 158. 251UdR for tumor targeting in vivo, 154.
Diabetes mellitus, diastolic dysfunction, 91. Fourier amplitude analysis, quantitative, 81. 125) anti-CEA MoAb, radioimmunoguided
— systolic function, 91. surgery, 205.
Diabetic gastroparesis, erithromycin thera- 251 labeled monoclonal antifibrin antibodies,
py, 209. G S 1-151.
Digitalis-like factors, 41. ‘311 chromatographic procedures in thyroid
2-dimensional imaging, S II-108. §’Ga-citrate scan, 341. cancer, 144.
3-dimensional imaging, S II-108. — in juvenile Hodgkin’s lymphoma, 99. — therapy in thyroid carcinoma, 191.
Dipyridamole 7°'TI SPECT, S$ II-155. — in pulmonary scintigraphy in AIDS pneu- — thyroid cancer, 122.
— myocardial scintigraphy, S II-73. monias, 216. '311_Ber-H2 monoclonal antibody, 126.
— scintigraphy, S II-161. — in pulmonary tubercolosis, 214. 311_MIBG, therapy, 80.
— echocardiography, S II-144. Gastric emptying, diabetes, 209. 1317. MOv18 and ovarian cancer, 116.
— radionuclide angiography, S II-140. Gastro-esophageal reflux, children, 82. 311 therapy in thyroid adenoma, 150.
— test, S II-139. Gastrointestinal tumor, serum neopterin, 31]_MIBG scintigraphy, neuroblastoma, 146.
— test, and 7°'T] split dose, 105. 167. 1311-MIBG, pulmonary endothelial function,
— *!T| myocardial scintigraphy, 225. Gastrointestinal tumors and IUdR injection, 148.
Dobutamine echocardiography, 280. 154. Immunodetection of human atherosclerosis
— infusion, S II-166. — immunoscintigraphy, 96. plaque, S II-151.
— radionuclide ventriculography, S II-166. Gated radionuclide ventriculography, hemo- Immunometric tests, quality control proce-
— stress test, S II-141. dynamic influence on liver, 164. dures, 196.
— test, and radionuclide angiocardiography, — tricuspid regurgitation, 164. Immunoscintigraphy, lung cancer, 128.
105. GFR determination, weighting factors, 193. — malignant melanoma, 159.
— stress radionuclide angiography, 232. Gonadal function in thalassemia intermedia, — with °™Tc-F023C5-IgG1, 96.
Down’s syndrome, thyroid abnormalities, 103. 111Ty antimyosin antibodies, $ II-56, S II-91.
198. Graves’ disease, metimazole, 192. 'T-anti-CEA-F(ab’)2, bladder cancer, 78.
Doxorubicin, organ distribution and phar- — thyroidectomy, 197. — immunoscintigraphy, 69, 78.
macokinetics, 218. Gynecological malignancies, serum CA? as- 'In-DTPA, colon scintigraphy, 228.
— treatment in hepatocellular carcinoma, say, 131. — oral administration in children, 228.
218. 1111n-Iabeled F(ab’), 27.
Dynamic line phantom, 141. 1Tn-leukocyte scintigraphy, in Crohn’s di-
H sease, 93.
ses 3 33,
E Heart contractile reserve, S II-141. Inflammatory foci, scintigraphy, 92.
Heart transplantation, 2. Insulin dependent diabetics, S II-150.
Echocardiography, 241, 284. Hepatic cancer, serum tumor markers, 221. — metabolism in diabetes, 213.
— planar myocardial scintigraphy, 177. Hepatic portal index, radionuclide angiogra- Intimal medial thickening, scintigraphy, 171.
Echo-Doppler flowmetry, 309. phy, 186. Iodine prophylaxis, thyroid diseases, 133.
Electrocardiographic exercise test, S II-144. Hepatoblastoma, childhood, 210. Ischemia, postexercise "Tc-MIBI, 195.
Endemic goiter, iodine prophylaxis, 133. Hibernating myocardium, S$ II-118, $ II-126. Ischemic heart disease, S II-157.
Endocrinological effects, TRH T i.v. infusion, HIV infection, serum neopterin, 185. Ischemic left ventricular function, nuclear
174. HIV-1, encephalopathy, 180. angiography, 217.
Epilepsy, 319. Hodgkin’s disease, immunoscintigraphy, 126. Ischemic stroke, cerebellar diaschisis, 189.
Equilibrium gated angiography (EGRA), S HPLC, immunoscintigraphy, 212. -— muscular tone, 189.
II-139. — labeled hormone, 143.
Esophageal emptying, in achalasia, 87. Hydrocephalus, brain perfusion, 215.
Esophageal motility disorders, manometry, Hydroxyl-apatite, arthroplasty, 175. J
220. Hyperacute rejection, S II-52.
— radionuclide esophageal transit study, Hyperbaric oxygen treatment, toxic effects, Juvenile Hodgkin’s lymphoma, and °Ga
220. 176. scan, 99.
THE JOURNAL OF NUCLEAR BIOLOGY AND MEDICINE Vol. 36 - 1992
SUBJECTS INDEX
K Myocardial radionuclide angiocardiography, PET with FDG in brain GMR measurements,
81. 108.
Kidney radionuclide imaging, 309. Myocardial metabolism, fatty acids, 70. Pharmacokinetics, 7.
Kidney transplantation, renal function, 184. Myocardial perfusion imaging, S II-22, S Pheochromocytoma, ['*'IJMIBG therapy, 80.
— renal function reserve, 125. 1-29, S II-149. — imaging and laboratory tests, 161.
— transplant, 125. — with ™™Tc-Q12, 194. — sporadic and familial, 161.
Myocardial perfusion scintigraphy, S II-161. Picture archiving communications system,
Myocardial reperfusion, S II-113, S II-139. ee
L Myocardial revascularization, S$ II-97. Pituitary-thyroidal response, in cardiac sur-
Myocardial scintigraphy, 26, S II-9, S I-97. gery, 203.
Left bundle branch block, S I-153. Myocardial SPECT, S II-160. Planar myocardial scintigraphy, S II-157.
Left ventricular function, S II-146. —°°™Tc-MIBI, 200. Plasma bone Gla protein, radiological fin-
— in essential hypertension, 134. — ['71]P-IPPA, 200. dings, 166.
— monitoring, S II-82. Myocardial viability, 253, 259, 267, 284, 241, Plasma cell discrasias, 303.
— perfusion, S II-146. 243, S I-62, S$ II-91, S I-97, S 11-118, S Post-MI ischemia, S II-157.
Left ventricular systolic and diastolic func- II-122, S II-126, S II-157, S II-163, $ II-166. Prostatic cancer, follow-up, 76.
tion measurements, 168. Prostatic specific antigen, 76.
Ligands, 296. Pulmonary emboli, S$ II-35.
Liver cirrhosis, radionuclide angiography, N Pulmonary scintigraphy in AIDS pneumo-
186. nias, °’Ga, 216.
Liver, focal nodular hyperplasia, scintigra- Nephrolithiasis, ESWL, 167. — *™Tc-HIG, 216.
phy, 107. Neuroblastoma, tomography and ultrasound Pulmonary tubercolosis, §7Ga, 214.
Low T3 syndrome, in loco, regional anaesthe- imaging, 146. — °™Tc-HIG, 214.
sia and narcosis, 127. Neuroendocrine tumors, monoclonal antibo- Pyramid segmentation method, in PET, 83.
Lung cancer and ['?'I]MIBG, 148. dies, 150.
— immunoscintigraphy, 128.
Nimodipine, chronic cerebral insufficiency,
Lung surgery, ventilation outcome, 178. 227 Q
Lunsgf unucpttiaokne, as1 4m0a. rker of left ventricular di- Nitrates redistribution, S II-159. Q-12, °™Tc radiotracer, 114.
Lymphoscintigraphy, internal mammary, 96. — vasodilation, S II-163. — as myocardial perfusion agent, 114.
Nitroimidazole, 60. Quality control, MAG, 373.
Nuclear medicine, future, 337.
Nuclear medicine techniques in cardiology,
M
287. R
MAG3, quality control, 73. Radiopharmaceutical tracer, S II-108.
— renal function, 73. Oo Radioimmunoassay techniques and quality
Malignant ocular melanoma, immunoscinti- control, renin and PRA, 137.
graphy, 2206. Obesity, 41. Radioimmunotherapy, metastatic gastrointe-
Medullary thyroid cancer, '?'I-MIBG thera- Office automation, in nuclear medicine, 100. stinal cancer, 189.
py, 80. One-vessel coronary disease, lung uptake of Radionuclide angiography, S II-160, S II-164.
est a ty 2 — and dobutamine test, 105.
MMMeeitgta9ra4sab.tio anlteii,cc abdnoidsn eea °se™c,aT ncce1-r4,H0 .M P'®A*ROh ibnrjaeicnt ioSn,P EC1T83,. OOvsatoresiotacenao ldcyciasnnt creorp,rh ayd,ii momiu1m6nm6o.us ncoianstsiagyr,a phy,ur em69i.c ———— dimlniiy vpoercyri argrihctdid riaramvhloeo nlstiersi ,is cctuhelse1ta8m,6ri . a 8,1f .u n8c1t.i on, 151.
Modulation transfer function determination, — radioimmunotherapy, 116. Radionuclide data, S II-152.
141. Radionuclide procedures, 273.
Monoclonal antibodies labeling, S II-32. Radionuclide ventriculography, S II-148.
Monoclonal antibody 4C11, S II-1460. P Radiosensitizer, 60.
Monoclonal antibody, '*I-labeled anti-Ta, Raynaud’s phenomenon, § II-149.
113. Pancreatic cancer, serum tumor markers, rCBF abnormalities," T'c-HMPAO ASPECT,
— chimeric, 33. 224. 205.
— murine, 33. Parathyroid scintigraphy, "Tc, 139. — '3X e inhalation, 205.
Monoclonal antifibrin antibodies, S II-35. — 71, 139. '86Re, bone pain, 183.
Monoclonal antiplatelet antibodies, S II-35. Parkinson’s disease, and D2 _ receptors — boron cluster, tumor cells, 123.
Mucin-like antigens, CA19-9, CASO, CA195, SPECT, 99. Regional wall motion, 280, S II-139.
95. Pediatric HIV, neurological disease, 153. Reinjection, S II-9, S I-15.
Multimodal medical images, 190. Perfusion myocardial scintigraphy, 232. Rejection, S II-56.
Multiple myeloma, 303. Perinecrotic ischemia, S II-155. Renal artery stenosis, 309.
— Serum neopterin, 185. Peripheral vascular disease, exercise 7°'T] Renal function and essential hypertension,
Myocardial imaging, S II-147. scintigraphy, 136. 145.
Myocardial infarction, S II-91, S II-102, S — spinal cord stimulation, 233. Renogram, quantitative analysis, 219.
II-113, S Il-144, S 11-155, S II-163, S 11-165. PET, 241, 267, 284, 324, S II-122. Renovascular hypertension, 309.
— acute, 20. — and cognitive functions, 324. Rest in ventricular function, S II-150.
— one-vessel disease, 153. — attenuation correction, 83. Revised Jones’ criteria, S II-154.
Myocardial ischemia, S I-97, S II-118, S — with FDG in ACTH-secreting pituitary Rhabdomyosarcoma, alveolar, 341.
1-122, S I-126. adenomas, 90. Rheumatic fever, S II-154.
Vol. 36 - 1992 THE JOURNAL OF NUCLEAR BIOLOGY AND MEDICINE
SUBJECTS INDEX
S °™Tc in migraine, 94. 201T! fixed defects, S II-158.
— in Parkinsonism, 107. 2017] Jung uptake, S$ II-156, S II-161.
Sarcoidosis, serum neopterin, 185. °°™T c-HMPAO granulocyte scintigraphy, 92. 201T! myocardial scintigraphy, S II-142, S
Schistosoma mansoni, 56. 99mTc-HMPAO SPECT in pediatric HIV, 153. II-144.
Scintigraphy, intimal medial thickening, 171. — brain, 147. 2017! perfusion scan, peripheral vascular di-
— liver, focal nodular hyperplasia, 107. — carotid atherosclerosis, 112. sease, 233.
Scleroderma, S II-149. — central nervous system, 112. 201T! perfusion scintigraphy, $ II-163.
Septal perfusion analysis, S II-153. — HIV-1 encephalopathy, 180. ?°!'T| redistribution, 243, S II-159.
Serotonin, anterior pituitary secretion, 158. — hypertension, 132. 20'T] reinjection, 88, 253, S II-155, S II-157,
Serum AFP, hepatoblastoma, 210. — Lupus, 112. S II-165.
Serum cals, and gynecological oncology, — nimodipine, 227. — redistribution imaging, 134.
131. °°™Tc-HMPAO, blood and brain kinetics, 2017] rejection scintigraphy, S$ II-62.
Serum myosin, immunometric assay, 111. 188. 2017] resting, S II-153.
— myocardial cell damage, 111. — cerebral perfusion, 173. 201T! scintigraphy, 259, 280.
Serum neopterin, HIV infection, 185. — hyperbaric oxygen treatment, 176. — arterial obstructive disease, 136.
— multiple myeloma, 185. — peritoneal dialysis, 186. 201T! stress test, 253.
— sarcoidosis, 185. — radiolabeled leukocytes, 186. 201T1 tomography, S$ II-155.
— tumor marker, 167. — transient global amnesia, 174. ‘Tl, and chronic coronary disease, 117.
Serum, free thyroxine, 113. °°™Tc-labeled HIG, lung infections, 202. — and SPECT in brain tumors, 101.
Severe stress and ”°'TI reinjection, 134. °°™Tc-MAA, aerosol, 181. 2017} ischemic and viable myocardium, 235.
Single kidney filtration fraction, effective re- — pulmonary perfusion, 178. 20l'T], perinecrotic and remote myocardial
nal plasma flow, 145. 99mTc-MAG3, renal function, 167. ischemia, 94.
— glomerular filtration rate, 145. — sphinterectomy, 179. 2017] redistribution and reinjection, 94.
Single vessel coronary artery disease, S °°™Tc-MDP, age-related whole-body, 224. 20171 |r est, myocardial infarction, 121.
11-155, S$ 11-156. — segmental zetention, 224. a8 split dose myocardial scintigraphy,
Sj6gren’s syndrome, xerotrachea, 180. °™T c-MIBI and coronary artery disease, 153. 105.
SPECT, alo. Tc-MIBI cardiac imaging, myocardial via- IT] kinetics, S$ II-15.
SPECT “Tc-MIBI, 74, 93, S II-141. bility, 160. Three-phase hone scintigraphy, 170, 175.
SPECT in nuclear cardiology, S II-108. Tc-MIBI imaging, chest pain, 223.
Thrombolytic therapy, S II-163.
— 7°!T] stress/redistribution, 169. — non-diagnostic ECG, 223.
Thymidine kinase radioenzyme assay, leuke-
— brain damage evaluation, 109. °™Tc-MIBI kinetics, $ II-130.
mia, 166.
— brain tumors, 74. °™T c-MIBI perfusion, myocardial infarction,
— breast cancer, 137.
— dopamine receptor, 107. 133.
Thyroid adenoma hyperfunction, pharmaco-
— in brain tumors with 7°'T1, 101. °°™Tc-MIBI SPECT, coronary artery disease,
logical treatment, 150.
— of D2 receptors in Parkinson’s disease, 99. 234.
Thyroid cancer, follow-up with '"I, 144.
Spinal cord injury, renography, 179. — IMA post thrombolytic therapy, 231.
— monitoring, 77.
Stress *'TI-SPECT, S$ II-140. 99mTc_MIBI, brain tumors, 74.
— multivariate analysis, 98.
Stress echocardiography, 273, S II-157. — first-pass ventriculography, 93.
Stress test, S II-156. — gated SPECT in coronary artery disease, — scintigraphy with '°1, 77.
Systolic left ventricular function, $ II-149. 89. Thyroid carcinoma, }*'I-total body scan, se-
— heart, 172. rum thyroglobulin, 201.
— neck high resolution ultrasonography,
— in coronary artery disease, 83.
T — left ventricular volumes, 195. 201.
— leg claudication, 118. — postsurgical treatments, 199.
TCA, labeled hormone, 143. — lung uptake, 140. — thyroglobulin, 191.
°™Tc-MIBI, 2, 241, 284, 315, S II-130, S — myocardial scintigraphy, 141. Thyroid function, Down’s syndrome, 198.
II-139. — parathyroid glands, 87. Thyroid nodule, 315.
— gated studies, S IJ-i53. — rest, myocardial infarction, 121. Transesophageal pacing, S II-162.
— imaging, S II-163. — SPECT in anterior myocardial infarction, — stress, 217.
— scintigraphy, 259, S II-162. a: Transient global amnesia, SPECT study, 174.
— SPECT, S II-167. — /SPECT and hybernating myocardium, TRH T, i.v. infusion, 174.
— uptake, S II-153. 146 TSH, 315.
Tc-propylene amine oxime, 46. °°™Tc-MoAb and lung cancer, 128. Trifluoroperazine, S II-113.
Tc-2 methoxy-isobutyi-isonitrile, 2. °°™Tc-Q12, biodistribution, 194. TSH immunoassay, hormone concentra-
" rn’ and immunoreactivity, 106, — biological behaviour, S$ II-29. tions, 236.
290. 9°™T c-teboroxime, ischemic and viable myo- Tumor, 60.
viimg. fe myocardial perfusion agents, 157. cardium, 235.
sont c-nitrido dithiocarbamates, S$ II-147. Tc-Tecnemab-K1, melanoma scintigra-
Tc phantom studies, S II-160. phy, 222. Vv
Tc-Teboroxime, S$ II-22. Tenascin, breast tumors, 230.
99™T c(II1) cation agent, S II-29. Testosterone, free, 20. Viability assessment, 273.
°™Tc, labeling of peptides, 106. Tetralogy of Fallot, surgical correction, long-
Tc, radiopharmaceuticals labeling, 229. term follow-up, 151.
Tc-DTPA renal sequential scintigraphy, Thalassemia intermedia, and gonadal func- Ww
145. tion, 103.
°°™Tc-ECD, blood and brain kinetics, 188. IT], 26, 241, 243, 284, S IL-5, S II-9, $ I-15, Werner’s test, Graves’ disease, 192.
Tc-F(ab’)2-antimelanoma, 162. S II-68, S II-102, S II-122, S$ II-144. Wolff-Parkinson-White syndrome, S II-140.
°™Tc-HIG, in pulmonary scintigraphy in — myocardial scintigraphy, 177.
AIDS pneumonias, 2106. — one-vessel coronary disease, 177.
Sail pulmonary tubercolosis, 214. 201T! antimyosin antibody, S$ II-91. x
Tc-HMPAO brain SPECT in AIDS demen- a imaging, myocardial viability,
tia, 125. 160. '3Xe, activation by pain, 200.
THE JOURNAL OF NUCLEAR BIOLOGY AND MEDICINE Vol. 36 - 1992
AUTHORS’ INDEX
Authors’ Index
A Bagnato A., 139, 202. Biassoni L., 75, 79. Caico S., 105, S II-141, S II-166.
Bagni B., 71, 72, 73, 74, 186, 287, Biassoni P., 91, 218. Calbiani B., S II-142.
Aas M., 33. S 11-159. Bicchi M., 227. Calcagni M. L., 139.
Abbati A., 141. Bagni I., 71, 72. Biggi A., 119, 174. Calzavara F., 96.
Acchiardi F., 174. Baldari S., S 11-9, 253. Binaghi G., S II-141, S II-166. Calzolari F., 74, 130.
Achilli M., 190. Baldi S., 185. Binderis N., S II-152. Camisa R., 138.
Acito P., S II-144, S II-157, § Ballerini E., 99. Bini V., 125. Campa P. P., S II-151, S I-163.
II-158, S II-165. Banci M., 207, S II-151, S II-163. Bisi G., 83, 206, 235, 287, S I-87. Campana M., 70, 93, 181.
Acquati F., 105, S II-141. Barabino A., 82. Boccato S., 198. Campini R., 93, 133, 140.
Acquati G., S II-166. Baranowska-Kortylewicz J., 154. Boccia S., 186. Campodonico R., S I-142.
Adamo C., 341. Baratto M. T., 143. Bogni A., 85. Camuzzini G. F., 119, 174.
Adao M., S II-161. Barbanti P., 173, 189. Bogni E., 210. Canavese G., 70.
Adelstein S. J., 154. Barbara L., 114. Bombardieri E., 52, 84, 85, 115, Candell J., S 11-149.
Adezati L., 91. Barbazza R., 107. 210. Candelpergher G., 234, S II-141.
Adversi I., 141. Barbera F., 75, 205. Bonanime A., 233. Canel F., S II-141.
Agnetti V., 208. Barbieri D., S II-159. Bonavina L., 87. Canna G. L., S II-126.
Agostini M., S II-32. Barizza C., 118. Bonavita V., 90. Cannizzaro G., 94, 253.
Aiello E., ., 76. Baroffio R., 169, S II-155. Bonazza A., 86. Cantalupi D., 223.
Alagna S., 102, 158. Baroldi G., S II-62. Bonazzi L., 125. Cantarano G., 175, 191, 192, 211.
Alfano B., 108. Barozzi L., 309. Bonelli P., 219, S II-150. Canu M., 208.
Alfieri O., 280, S II-126. Bartoccioni S., 203. Bonetti M. G., 109, 122. Cao P. G., 127.
Alonso F., S II-149. Bartolomei A., 226. Boni G., 77, S II-144. Caplan J., 26.
Alpern J., S I-52. Baschieri I., 191, 192. Boni S., 177, S II-156, S II-157. Caponnetto S., 91.
Altieri A., 223. Basilevich I., S II-152. Bonino C., 114, 126, 157, 194, S Cappa S. F., 324.
Amadori D., 138. Batagelj I., 92. I-29. Cappagli M., 94, 176, 253, S II-9.
Ambrogio L., 174. Batozzi R., 137. Bonow R. O., S II-122. Cappelli G., 95.
Ambrosio A., 101. Battaglio S., 185. Bonuccelli U., 94. Cappelli R., 227.
Ambrosio G., 215. Battistin L., 107. Borelli P., 93. Caputo M., 82, 153.
Ambu S., 214, 216. Beccati D., 128. Borgogni G., 225. Caputo M. T., S II-144.
Anastasi A. M., 207. Bellanova B., 76, 120, 157. Borsato N., 87, 107, 132, 200, Caraceni A., 176.
Ancidei S., 89. Belletti S., 119. 233, 234, S II-141, S II-160. Caraceni T., 140.
Andreani D., 213. Bellina C. R., 77, 144, 148, S Boschi M., 82, 153. Caracd C., 96, 101, 146, 161, 230.
Annicchiarico C., 131. 11-144. Bostrom P. A., S II-139, S II-146. Cardillo G., 220.
Antonacci P., 78, 99, 100, 184. Bello M., 78. Botti C., 84. Careddu A., 181.
Antonelli A. M., S 11-142. Bellone P., 79. Brambilla M., 88, 253, S II-9. Carena M., 69.
Antoni M., 202. Benatti U., 218. Brasacchio R., 127. Carlsson R., S II-146.
Aprile C., 69. Benzoni A., 253, S II-9. Brazioli R., 100. Carone R., 179.
Aravot D., 2. Berbellini A., 89. Brianzoni E., 89. Carpeggiani C., 111.
Arena A.I., 145. Bernardo-Filho M., 56. Briguglio E., 197. Carpinelli A., 114, 157, 194, $
Armandans V., S II-149. Bertelli P., 224, 225, 226, 227, Brill A. B., 7, 33. 11-29.
Armellini D., 127. 228, 255; 525. Brivio F., 69. Carrio I., S I-56.
Arosio M., 69. Berti S., 143. Brunetti A., 90, 108, 161, 215. Cary N., 2.
Arru A., 102, 103, 134, 181, 208. Bertocchi C., 231. Bruno M., 166. Casaccia M., 70.
Artioli M., 74. Bertoglio S., 205. Bruzzone F., 91. Casara D., 96, 98, 197, 198, 201.
Ascarelli A., 217. Bertolaccini P., 151. Budihna N., 92. Casati R., 114, 157.
Ashburn W., 26. Bertolazzi L., 79, 110. Buoncristiani U., 125. Cascarano M. T., 203.
Astegiano M., 93. Bertoli D., 253. Buraggi G. L., 52, 84, 85, 99, 115, Casi M., 189, S II-32.
Asteriadis I., 235. Bessone M., 78, 99. 116, 210. Castagnoli A., 188.
Astorri E., S II-142, S II-150. Bestagno M., 80, 119, 150. Burroni L., 224, 225, 226, 227, Castell J., S IIl-149.
Atcher R. W., 33. Bestetti A., 81, S 11-139. 228, 315. Castellani M. R., 52, 99, 115, 210.
Aucella F., 166. Betocchi S., S II-148. Bushe H. S., 7, 33. Castellano G., 78, 99, 100, 184.
Azzena M. D., 102, 103, 134, 208. Betti E., 82, 153. Busnardo B., 197, 198, 201. Castelli L., 96, 101, 146, 230.
Bettinardi V., 83, 176, 190. Buxeda M., S II-149. Castiglioni B., 105, S II-141, S
Bettini D., 167. II-166.
B Bevilacqua G., 154. Casu A. R., 102, 103, 113, 134,
Beyhan H., S II-140. C 158, 181, 208.
Baccega M., 70. Bhatia M. L., S II-154. Cataldi C., 235, S 1-9.
Bacci A., 125. Biagini A., 143. Cabassa N., 133. Catozzi L., 137.
Bacciardi D., 77. Bianchi M., 127. Cabassa P., 167. Cavalieri L., 159.
Baccichetti C., 198. Bianchi R., 77, 131, 143, 144, Cabria M., 79, 110. Cavallini A. R., 71, 72, 73.
Bacciottini L., 188. 148. Cacace G., 93, 193. Cavazzana G. F., 79.
Badellino F., 205. Bianconi A., S II-155. Cacciari N., 157. Cazzuola F., 143.
Bagnaroli F., S II-164. Bianconi B., 172. Caglar N., S II-140. Cefala L., 95.
Vol. 36 - 1992 THE JOURNAL OF NUCLEAR BIOLOGY AND MEDICINE
AUTHORS’ INDEX
Cei A., 154. D Di Palma E., 230. Ferraris R., 119.
Celegon L., S II-141. Di Pasquale G., 111. Ferraro C., 91.
Celmentano L., $ II-162. D’Addabbo A., 147, 162. Di Perri T., 225. Ferraro S., S II-148, S II-162.
Centi Colella A., 159, 207. D’ Agata A., 95. Di Piero V., 173, 176, 200. Ferreira R., S II-160, S I-161.
Ceppi G., 184. D’ Agostino R., S II-163. Di Stefano R., 154. Ferreira T. C., S II-161.
Cerchier A., 167. Daidone M. S., 199. Ditlow C., S II-35. Ferretti E., 211.
Ceriani L., 105, S II-97, S II-141, Dalla Pozza F., 118. Di Vagno G., 162. Ferro G. F., 119.
S II-166. Damiano M., S II-162. Dmitriev B., S II-163. Fesani F., S II-142.
Cerquetani E., S II-151. D’Amica A., 205. Donadel E., 151. Figueiredo A., S II-160.
Ceruti S., 74. D’Amico P., 69. Donato L., 337. Filesi M., 175, 191, 192.
Cerutti S., 190. D’Angeli B., 119. Dondi M., 76, 114, 120, 121, 253, Fiore V., 213.
Cervi P. M., 186. Danieli R., 207. 287, 309, S II-9, S II-164. Fioretti P., 131.
Cervi V., S II-164. Danzi G. B., S II-68. Doni M., 216. Fiorio P., 82, 153.
Cesana P., 70, 179, 193. Davis D. A., S I-52. Donner R., S II-52. Fiorucci G., 126, 172.
Chambron J., 20. De Agostini A., 119. D’Onofrio F., 90. Fischman A. J., S II-82, S II-157.
Chaplin S. B., 46. De Berardinis A., 70. Dore F., 103, 208. Flenghi L., 126.
Chapman J. D., 60. De Bernardi B., iid. Dottorini M. E., 122. Foggia L., 215.
Chen F., S II-35. De Besi P., 98. Dovigo L., 112. Fonollosa V., S II-149.
Chernov V., S II-152. De Cicco C., 223. Duatti A., 123, 124, S II-147. Fonseca A. T., S II-160.
Chianelli M., 106, 211. De Crescenzo S., 219. Duce T., S II-9. Fontani R., 227.
Chiarella F., 79. De Cristofaro M. T. R., 188. D’Ugo D., 220. Forconi S., 227.
Chiarello M., 117, S II-148, S De Fabriitis A., 309. Dunning J., 2. Formiconi A. R., 145, 219.
II-162. De Filippi P. G., 70, 93, 113, 167, Duse G., 118. Formisano R., 173, 189.
Chierichetti F., 87, 107, 132, 200, 179, 181, 185, 193. Dutto E., 78. Foti C., 153.
233, 234, S II-141, S$ II-160. De Filippo G., 232. Fraile M., S II-149.
Chiesa M. R., 236. De Flora A., 218. Franceschi G., 189, S I-32.
Chiriatti G., 141. De Giorgi L., 225. E Franceschini R., 148.
Chiti A., 81, S II-139. De Jesus Nascimento Reis R., 56. Franchi R., 121.
Ciancarella W., 207. D’Elia F., 154. El Rahman Sharif A., S II-146. Franzellin F., 133.
Ciarmiello A., 108, 172. Del Chicca M. G., 41, 111, 230. Emdin M., 111. Frattaruolo M., 77.
Ciavolella M., S 11-151. De Lisi, V., 219. Erhardt L., S II-140, S II-146. Fravretto G., 253.
Cionini R., 41. Della Dora R., 69. Erol C., S II-140. Freitag M., S II-139.
Ciravegna B., 153. Della Vittoria G., S II-144, S Esposito G., 96, 215. Frigerio C., 225.
Ciritella P., 109. II-157, S II-158, S 11-165. Evancelista M., 96. Fringuelli F., 192.
Cittanti C., 109, 112, 124, 136. Del Rio P., 230. Frontera D., 221.
Ciuffetti G., 171. De Maria R., S II-62. Frusciante V., 166.
Claudiani F., 79, 110, 181. Demolli V., S 11-141, S II-166. F Fulham M. J., 90.
Clausen M., 164. Denaro A., 174.
Clerico A., 41, 111, 143, 236. De Paoli E., 186. Facchetti L., 140.
Coccolini S., 253, S II-9. Derchi G., 79. Faggioli R., 130. G
Codella C., S II-148. De Rosa G., 203. Fagioli G., 125.
Colamussi P., 109, 112, 136. D’Errico G., 161, 221. Fagret D., S II-147. Gabbani S., 141, 153.
Coli A., 94, 113, 176. De Santi M. S., 101. Fagugli R. M., 125. Gadducci A., 131.
Collecchi P., 154. De Santis M., 199. Falini B., 126. Gagliardi R., 176.
Colloridi V., 207. De Santis R., 207. Fallani F., 121, S II-130, S II-164. Galassi A. R., S II-68.
Colombi L., 122. Deserra F., 208. Falloni M., 184. Galati M. G., 96.
Colombo F., 114, 146, 157, 194, De Simone A., 101, 215. Falorni A., 125. Galeotti M., 125.
S 11-29. Deutsch E., 114, 157, 194, S II-29. Fanelli R., 177, S II-156. Galli G., 139, 202, 220.
Comazzi F., 133. Deutsch K., 114, 157, 183. Fanti S., 120, 309. Galli L., 146.
Comet M., S II-147. De Vita A., S II-153. Faralli F., 176. Galli M., 93, 133, 134,140, 243,
Comis G., 219. Devoti G., 223. Farinelli M. C., 174. 287, S II-102.
Consoli V., 341. Di Bello V., S II-144. Farris A., 102. Gallo V., 98.
Conti U., S$ II-144. Di Caprio P., S 1-153. Fatigante L., 148. Gamberini S., 186.
Contini G. A., S II-142, S II-150. Dicembrino F., 177, S II-157. Favretto G., S II-9. Ganau A., 134.
Conzi G.F., 205. Di Chiro G., 90. Fazio F., 83, 114, 140, 146, 150, 157, Ganga A., 208.
Conzo G., 96. Di Credico G., 146. 169, 176, 190, 194, 324, S I-29. Garancini S., 105, S II-141.
CorbelliC. , 76, 114, 121, S II-164. Diemer H., S II-139, S II-146. Fazzi P., 341. Garibaldi C., 75, 205.
Corlija M., 46, 296. Di Fazio P., 109, 222. Fazzini P.F., 206. Gasparini M., 52, 85, 99, 115,
Corrado G., 76. Di Fronzo G., 138. Fedeli L., 125, 126, 127, 171, 172. 116, 210.
Covelli E. M., 215. Di Guglielmo E., 186. Fedorov A., S II-152. Gasser F., 20.
Crippa F., 52, 85, 99, 115, 116, Di Leo C., 194, S II-29. Feggi L., 73, 128, 130, 186. Gattucci M., 171.
210. Dillon W., 26. Feggi L. M., 303. Gavaruzzi G., 219, S II-150.
Cruccu G., 200. Di Loreto M., 207, S II-151. Ferdeghini M., 77, 113, 131, 144. Gavasso S., 197.
Cuocolo A., 117, 160, 161, 168, Di Luca L., 154. Ferlin G., 87, 107, 132, 196, 200, Gavoni N., 116.
S II-153, S II-163. Di Macio L., 207. 233, 234, 287, S II-141. Giampietro O., 41.
Curcio C., 84, 85. Di Marco S., 141. Ferracuti S., 200. Gianni M. C., 210.
Cusella-De Angelis G., S II-151. Di Niro M., S II-164. Ferrari R., S II-126. Giannuzzi P., 93, 133, 140.
THE JOURNAL OF NUCLEAR BIOLOGY AND MEDICINE Vol. 36 - 1992
AUTHORS’ INDEX
Giganti M., 109, 112, 124, 136, I Lomuscio G., 122. Martinelli V., 231, S II-167.
137, 138, 287. Longinotti M., 103. Martoni A., 157.
Gigli G., 273. Ianni A., 341. Losinno F., 309. Marullo Reedtz A., 139.
Gilardi M. C., 83, 140, 146, 190, Icardi G., 141, 153, 214, 216. Lucignani G., 146, 176. Marzocchi S., 73.
324. lervasi G., 77, 143, 144, 236. Lunghi F., 148, 194. Marzullo P., 241, 259, 284, S
Gilli G., 72. Iesi A. P., S II-155. Lupatelli G., 171. II-118.
Ginanni A., 158. Imbriaco M., 117, S II-153. Lupetti M., 153. Masala A., 102, 158.
Giobbe D., 99. Inglese E., 253, 287, S II-9. Lusa A. M., 111. Masarotto G., 98.
Gion M., 138. Iskandrian A., S II-73. Lusiani L., 233. Mascoli F., 136.
Gionet M., 7. ho T.,, 33: Luzi S., 199. Masi R., 178, 188.
Giordano A., 76, 93, 114, 133, Massa R., 159.
139, 253, S IL-9, S II-102. Massimino M., 210.
Giordano G., 127. J M Mastropasqua G., 107.
Giorgi C., S II-144. Matarrese M., 140.
Giovanelli M., 169. Janicek M. J., 319. Machado e Silva J. R., 56. Matera R., 166.
Giovannini G., 137. Johnson L. L., S II-91. Macrina F., S II-151. Mather S. J., 106.
Girelli M. E., 197, 198, 201. Juhlin P., S II-139. Maddalena G., S II-148, S II-162. Mathieu A., 181.
Giubbini R., 93,133, 140, 195, Madeddu G., 102, 103, 113, 134, Matteucci F., 77, 144, S II-144.
280, 287, S II-126. 158, 181, 208. Mattis J. A., 7.
Giuliani L., 154. K Maecke H., 169. Maurea S., 146, 160, 161, S
Giuliano A. L., 109. Maffioli L., 52, 99, 115, 210. II-153.
Giuliano G., 213. Kanke M., S II-35. Magagnini E., S II-144. Maurelli L., 146, 161.
Giuntini C., 14, 341. Karpov R., S II-152. Magliani L., 205. Maussier M. L., 161, 203, 221.
Giusti C., S II-144. Kassis A. I., 154. Magnani B., 287, S II-3. Maver P., 76.
Giusti S., 151. Katayama H., S I-82. Magnani P., 150, 169. Mazzoni A., 231.
Gokcora N., S II-140. Katti K. V., 296. Magnati G., S I-150. Mazzucchelli L., 122.
GonzalesJ . M., S II-149. Khaw B. A., S I-35, S t-113, S Magri G. C., 80, 119. McKenzie E. H., 46.
Gotti R., 231. 11-146, S 1-154. Maietta L., S II-164. McKusick K. A., S II-5, S II-157.
Grandolini S., 126. Klain M., 161. Mainolfi C., 90, 101. Medolago C., 231.
Kock P., 169. Maioli M., 134.
Granone P., 220. Meidolesi U., 83, 145, 188, 206.
Kumar P., 60. Maira G., 80, 119, 150.
Grassi F., 140, 170. Mele A., 207, S II-151.
Kwiatkowski M., 114, 194, S$ Maiuro G., 202.
Grasso E., 174. Mele M., 102, 162.
11-29. Malacarne F., 186.
Gravili $., 86, 253, S II-9. Mellino R., 102, 103, 134, 208.
Malagnino G., 131.
Gravina E., S II-148. Melo J., S II-160.
Malhotro A., S II-154.
Greco C., § II-151, S II-163. Mendes Boasquevisque E., 56.
L Maltinti G., 341.
Greco G., 226. Menneghetti G., 132.
Malvano R., 113, 236.
Gregori G., 41. Mennuti A., 141, 153, 214, 216.
L’Abbate A., 111, S II-118. Manca A., 119.
Griffin T. W., 7, 33. Merati I., 69.
La Canna G., 280. Maneschi A., 151.
Grimaldi G., 215. MercerJ . R., 60.
La Cava G., 145, 219. Manfredini G., 151.
Grossi A., 146. Laghi Pasini L., 225. Manfrini S., 136. Mercuri M., 171.
Grummon G., 157. Landoni C., 146. Mango L., S II-153. Merlo L., 73.
Guadagni A., 154. Landoni F., 69. Mangoni Di Santo Stefano M. L., Messeri G., 138.
Guardigli G., S II-159. Langer M., 103. 168. Messina M., 228.
Guerra L., 69. Large S., 2. Manicardi E., 209. Metra M., 195, S II-126.
Guerrero L., S II-113. Lastoria S., 96, 101, 146, 161, Manna R. H., 60. Meucci D., 228.
Guerrini M., 227. 230. Mannarino E., 172. Meucci G., 154.
Guglielmi G., 166. Lauriero F., 147. Manni C., 159. Migliorato A., 253, S II-9.
Guida C., 166. Lavarini L., 153. Mannini D., 76. Miguel M. B., S II-149.
Guidarelli G., 141. Lazzeri E., 148. Manzara A., 82, 153, 181. Milan E., 140, 195, S II-126.
Guideri F., 225. Lecayon M., 124. Marabotti C., S II-41. Milcinski M., 92, 164.
Gullini S., 186. Lemmo G. F., 221. Maranetto F., 78, 184. Milella M., 94.
Ginalp B., S II-140. Lenzi G. L., 173, 189, 200. Marcassa C., 133, 134, 243, S Modoni S., 109, 166.
Girel T., S 11-140. Leoncini F., 214, 216. 11-102. Molea N., 77.
Leoncini M., 83, 206. Marcucci G., 141, 153, 214, 216. Mondi M., S II-130.
Leoncini R., 94, 176. Mardirrosian G., 7, 33. Monetti N., 114, 120, 121, 309,
H Leone A., 119. Marenco S., 205. S II-164.
Leone G., 223. Marengo M., 229. Mongioj V., 116.
Haber F., S II-146. Levorato M., 76, 120. MarianGi. , 77, 148, 154, S II-144. Montemaggi P., 199.
Hasson-Voloch A., 56. Librera M., S II-148. Mariani M. A., 146. Montepagani A., 94, 176.
Henze E., 164. Lilja B., S 11-139, S 11-146. Marinelli M., 123. Moragas G., S II-149.
Heo J., S I-73. Lion R., 118. Marini A., 116. Mordovin V., S II-152.
Higgenbotham C., 296. Lishmanov Y. U., S II-152. Marino B., S II-151. Morello P., 99, 100, 184.
Hines J. J., 33. Lodi L., 186. Marmion M., 114, 157. Moretti R., 119.
Hnatowich D. J., 1, 7, 33. Lodi M., 128. Marques M. S., S II-160. Morisco C., 117, 160, S II-153.
Hoffman T. J., 46, 296. Loi G. L., 181. Martelli M. F., 126. Mosca F., 154.
Holmes R. A., 46, 296. Lomuscio A., 81, S II-139. Marterelli L., S IIl-163. Mosca R., 148.
Vol. 36 - 1992 THE JOURNAL OF NUCLEAR BIOLOGY AND MEDICINE
AUTHORS’ INDEX
Moscatelli G., 189, 253, S II-9, S Pampolini M., 128. Pino G., 205. Rizzo G., 83, 190.
IIl-144, S II-157, S 11-158, S$ Panarotto M. B., 80, 150. Piotto A., 197, 201. Rodrigues M., S II-160, S II-161.
11-165. Pancaldi D., 229. Pipes D., 183. Rodriguez G., 205.
Mosso R., 93, 167, 185, 193. Panico M., 172. Piraccini R., 161. Rogasi P. G., 214, 216.
Mullins P. A., 2. Pannuti F., 157. Pirelli S., 94, 253, S II-68. Romanini L., 175.
Murolo M., 205. Pantano P., 173, 189, 200. Pirronti T., 202. Romano M. F., S II-144.
Musto P., 166. Paolini G., 146. Pisano M., 134. Romei F., 218.
Muttini P., 82, 153, 181. Papaleo A., 174. Pistolese M., S II-153. Romolo G., 140.
Papi F., 125. Pizzichetta M., 52, 85, 115. Roncari G., 105.
Papi L., 141, 153. Pizzocaro C., 80, 150. Ronga G., 175, 191, 192, 213.
N Pappagallo R., 83. Pizzolato G., 107. Ropolo R., 93, 167, 179, 185 193.
Pappalardo A., S II-155. Podio V., 78, 99, 100, 184. Rosadini G., 205.
Nappi A., 117, 160, 168, $ II-153. Pappone C., S II-162. Poggesi L., 145. Rosati G., 208.
Naro F., S II-151. Paradiso A., 138. Poggi P., 94, 176. Rossato A. Q., 107
Narula J., S 11-35, S II-113, S$ Pareschi L., 73. Pogrebnaya G., S II-163. Rossetti C., 114, 146, 157, 194,
II-146, S II-154. Parmegiani M., 174. Pollo B., 169. S I-29.
Navalesi R., 41. Parodi O., 94, 241, 267, 284, S Polloni R., 167, 185. Rossi A., 141.
Neglia D., S II-41. II-41, S II-62. Polo G., 196. Rossini P. L., 140, 150, 195, S
Nerli A., 214, 216. Paserio E., 175, 191, 192. Porenta M., 92. II-126.
Nguyen P. T., 26. Pasqualini R., 124, S II-147. Portioli I., 209. Rota G., 196.
Nicol P., S II-113. Pastena L., 176. Possati G. F., 203. Rottoli L., 99.
NicolaiE. , 117, 160, 168, S II-153. Paties M., 86. Poti C., 82. Rovasio P. P., 102, 158.
Nieman L., 90. Pau F. M., 181. Pozzan G. B., 198. Roveda L., 69.
Nobili F., 205. Pavlica P., 309. Pozzilli P., 211, 213. Roy S., 7.
Noia P., 219. Pavlyukova E., S II-152. Pradella A., S II-159. Rubello D., 96, 98, 197, 198, 201.
Nosadini A., 86. Pazzini P. F., 83. Prandella A., 287. Rubini G., 147, 162.
Nosco D., 157. Pelagi M., 150. Prandini N., 128, 186, 303. Rubini S., 147.
Nuti A., 94. Pelizzo M. R., 197, 201. Prati U., 69. Ruffini L., 81.
Nuvoli S., 102, 103, 134, 208. Pelizzola D., 137. Prontera C., 113, 131. Rufini V., 199.
Pellegrini A., S II-62. Puccini G., S II-41. Ruggeri G., 138.
Penno G., 41. Pupi A., 188. Rusckowski M.., 7.
O Pera A., 93. Russo P., S II-52.
Peracchia A., 87. Russo R., 94, 113, 176.
Oberle P. A., 46. Perani D., 140, 176, 324. Q
Oliva G., 222. Perla F., 174.
Oltrona L., S II-62. Perna G. P., 177, S II-156, S Quarantelli M., 108. S
Omedé P., 185. II-157.
Omiirlii K., S 11-140. Perno G., 174. Sa E. P., S II-160.
Oral D., S II-140. Perrone E., 109, 166, 177, 222, R Saba P. S., 134.
Orlandi C., 223, 287. S II-156, S II-157. Sabalich I., 125, 171.
Ortona L., 202. Pesciullesi E., 178. Radely K. S., S II-154. Sabatini U., 189, 200.
Orvieto E., 137. Petix N. R., 141, 153. Raise E., 125. Sacquegna T., 125.
Orzincolo C., 303. Petracca Ciaravella G., 166, 222. Raise G., S II-150. Saito T., S II-35.
Osele L., 167. Petrella G., 230. Rampini S., 195. Saitta B., 87, 107, 132, 200, S
Osman Farah J., 211. Pezzullo L., 96. Randazzo G., 172. 11-160.
O’Tuama L. A., 319. Piantino P., 167. Randazzo M.., 79. Saladini G., 96, 98, 201.
Picano E., 273. Randone A., 167. Salassa B., 185.
Piccalo G., 94. Rapellino M., 185. Saletnich I., 161, 221.
P Picciocchi A., 220. Rassu S., 158. Salgado L., $ II-161.
Picciotto G., 179, 193. Ravazzi P. A., 231, S II-167. Salimi A. R., 33.
Paccagnella A., 219. Piccolo M., 197, 198. Ravera G. B., 75. Salustri A., 232.
Pace L., 117, 160, 168, S II-153, Picozzi R., 169, S II-155. Rebelo J. R., S II-161. Salvadori P. A., 148, 154.
S II-162. Pieri P. L., 253, S II-2, S 11-9, S Redaelli S., 151. Salvatore M., 90, 96, 101, 108,
Paganelli G., 146, 150, 169, 194, I-22, S Il-113, S$ 11-144, $ Reverberi R., 186. 117, 146, 160, 161, 168, 172,
S I-29. II-157, S II-158, S II-165. Ribuffo D., 159. 215, 230, S 11-153, S II-162.
Pagliaini R., 80. Pietravalle G., 232. Ricci M., 173, 189, 200. Salvatori M., 199, 202.
Pagliarini R., 150. Piffanelli A., 109, 112, 124, 136, Ricciardelli B., 117. Salvia S., 90.
Pala R., 181. 137, 138, 287. Riccipetitoni G., 73. Salvo D., 209.
Palagi B., 169, S II-155. Piga G., 134. Righi V. A., 175, 191, 192. Salzillo F., 147, 162.
Paleani Vettori P. G., 222. Piga M., 103, 181. Rigon A., 96. Sambuceti G., 259, S II-41, S
Palermo F., 253, S II-9. Pigorini F., 181. Rigon F., 198. 11-62.
Palermo S., 170. Pilo A., 143, 236. Ripani G., 127. Santaniello B., 75.
Palla A., 14. Pinato G. P., 118. Risa M. P., S II-155. Santini L., 96.
Palombo C., S II-41. Pinelli G., 111, 287. Ritrovato G., 166. Santomauro M., S II-148, S II-162.
Palumbo R., 125, 126, 127, Pingitore A., 273. Riva A., S II-41. Santoro G., S II-144.
171,172. Pinna A., 158. Riva N., 189, S I-32. Santoro G. M., 83, 206, 235, S
Pamir G., S II-140. Pinna L., 74. Riva P., 189, S I-32. II-87.
THE JOURNAL OF NUCLEAR BIOLOGY AND MEDICINE Vol. 36 - 1992
AUTHORS’ INDEX
Sapin R., 20. Spanu A., 102, 103, 134, 158, Tonfoni R., 341. Villa G., 75, 91.
Saponaro R., 69. 208. Toraldo A., 170. Villa M., 231, S II-167.
Sara R., 94, 219, S IL-9. Spinelli A., 189, S II-32. Toraldo P., 125, 172. Villavecchia G. P., 79, 110.
Sargiotto A., 93, 179. Spremberg F., 174. Torre L., 231. Vinattieri M. A., 214.
Sarobba M. G., 102. Stanghellini V., 114. Torresin A., 219. Violino P., 119.
Sarnelli R., 341. Stanislao M., 177, S II-156, S Toscano A., 211. Virotta G., 231.
Sarullo F., S II-9. II-157. Tota G., 228. Viscardi E., 110.
Satta L., 181. Stefanini G., 234. Trani C., 253. Visentin E., 69, 118.
Satta M. A., 203. Stein H., 126. Tremolada C., 86. Visioli O., 280.
Savi A., 83. Stimamiglio P., 110. Treves S. T., 319. Vitale L., 232.
Scarpa P., 130. Stone D., 2. Trimarco B., 117, 160, 168, S Vitek F., 143.
Scarpato F., 113. Strauss H. W., 291, S I-22, S$ II-153. Vognenzi A., 73.
Scarti L., 235. 11-35, S II-89, S II-113, S II-146, Triss S., S II-152. Volkert W. A., 46.
Scattina M., 231, S II-167. S II-154, S II-157. Troncone L., 199. Volpe L., 41.
Schenone F., 205. Striano G., 83, 140, 176. Truci G., 169. Volpi V., 145.
Schiavoni G., S II-9. Sudati F., 169. Turba E., 125.
Schillaci O., 207, S II-163. Suzzi G. L., 234. Turchi S., 143, 144.
Schinco G., 221. Turco G. L., 78, 99, 100, 184. Ww
Schlienger J. L., 20. Turco S., S 1-148.
Schofield P. M., 2. T Wallwork J., 2.
Sciagra R., 83, 145, 206, 235, S Watson D. D., S II-15, S II-108.
II-87. Tagliagambe L., 105, S II-141, S U Weller R., 164.
Scicchitano D., 170. 11-166. Weng S. Q., 83.
Scopinaro F., 207, 213, S II-151, Taki J., S I-82. Uccelli L., 109, 112, 124, 136, Westin L., S II-146.
S 11-163. Talarico L., S II-144. 137. Wiebe L. I., 60.
Scopinaro G., 79, 110, 181. Tallia R., 100. Ugolotti G., 219. Wilson A., 90.
Scott J., 2. Tamaki N., S II-82. Uthurralt N. M., S II-155. Wolf P., 118.
Scuncio G., 174. Tamarozzi R., 74. Wolfangel R., 183.
Scutellari P. N., 303. Tandon R., S II-154. Vv Wolkert W. A., 296.
Sechi G. P., 208. Tanzilli G., S II-163.
Selvi A., 125. Tarchi R., 141, 153, 214, 216. Vaccari A., 195. Y
Semplicini A., 132. Targagni F., 121. Vaggelli L., 178.
Serafini D., 209. Tarolo G. L., 81, S II-139. Valentini G., 89. Yasuda T., S II-82, S II-134, S
Seregni E., 52, 84, 85, 99, 115, Tartaglione G., 217. Valenza V., 161, 203, 220, 221. 11-154.
116, 210. Tartaglione M., 217. Valle G., 109, 177, 222, S II-156,
Sevelev V., S II-163. Tartagni F., S II-3, S I1-130, S S 11-157.
Shealy D., 7. 11-164. Valli A., 221. Zz
Siccardi A. G., 150. Tassi C. L., 150. Van Den Abeele A. D., 154.
Sicolo M., 118. Taurino M., S II-151. Vangelista R., 69, 118. Zaffin M., 69.
Siebecker D. A., 7. Tavazzi L., 93, 133, 287. Vania A., 207. Zagni P., 76, 114, 121.
Siepi D., 171. Tavella N., 131. Vanoli G., 146, 194, S II-29. Zamagni C., 157.
Signore A., 106, 191, 211, 213. Tavolaro R., 207. Varetto T., 223. Zanco P., 87, 107, 132, 200, 233,
Signori C., 159. Tedeschi G., 90. Vargiu S., 77. 234, S II-141, S II-160.
Signorini C., 145. Temporelli P. L., 93, 133. Vattimo A., 224, 225, 226, 227, Zanni D., 219.
Silvestri M., 141, 153, 214, 216. Tentoni C., S II-164. 228, 315, S IL-9. Zappone C., 231.
Simeon P., S II-149. Terreni M., 169. Vecchi F., 76, 157, 229. Zardi L., 230.
Smirnov A., S II-163. Terzi A., 80. Vella A., 235. Zenorini A., 169.
Smith W. H., S II-108. Tessaro L., 233. Ventriglia F., 207. Zerauschek F., 235.
Sobrero A., 218. Testa D., 140. Ventura G., 202. Zibera C., 138.
Solfanelli S., 341. Testa R., S II-62. Vergara E., 96, 101, 146, 230. Zito F., 83, 169, 194, S II-29.
Somayaji V. V., 60. Tisei A., 207. Verna E., 105, S II-97, S II-141, S$ Zocchi E., 218.
Songini C., 150. Tison V., 189. 11-166. Zoccola R., 181, 231, S$ II-167.
Soranzo M. L., 185. Tisselli A., S II-144, S II-157, S Veronesi P., 85. Zoccorato O., 93, 133, 134, 140,
Soricelli A., 90, 101, 215. 11-158, S 11-165 Versari A., 209. 169.
Sostegni R., 93. Todde S., 176. Verzini F., 127. Zorat P. L., 98.
SouthernJ . F., S II-154, S II-151. Todino V., 191. Verzuri M. S., 225. Zuccala A., 309.
Spadoni I., 151. Tola M. R., 112. Viacava P., 154. Zuccari M., 146.
Spandonari T., 99, 100, 184. Tomasella G., 201. Viglietti A., 119. Zucchelli G. C., 111, 236.
Spanedda R., 303. Tonetti M., 218. Vignati A., 122. Zucco M., 94.
Vol. 36 - 1992 THE JOURNAL OF NUCLEAR BIOLOGY AND MEDICINE